Bromodomain PHD finger transcription factor pseudogene 1 (BPTFP1)

Bromodomain PHD finger transcription factor pseudogene 1 (BPTFP1) is a noncoding pseudogene in the human genome related by sequence homology to the functional BPTF gene, which encodes a protein involved in chromatin remodeling and transcriptional regulation[1][5]. Pseudogenes such as BPTFP1 resemble functional genes but typically contain sequence defects (such as frameshifts or premature stop codons) that prevent them from producing a functional protein product[5][7]. As a pseudogene, BPTFP1 is not considered a canonical therapeutic target, receptor, enzyme, transporter, or transcription factor, and does not have a known direct biological, disease, or pharmacological function[1][5][7].\nIn general, some pseudogenes can participate in regulation at the RNA level (such as miRNA sponging or regulation of their parent gene transcripts), but there are no specific studies implicating BPTFP1 in such functions[3][5]. Whereas its parent gene, BPTF, is implicated in cancer and is a potential drug target, BPTFP1 itself is not[2][6].\n\nKey distinctions:\n- BPTFP1 is a **pseudogene**, not an active protein or RNA target.\n- It is occasionally mischaracterized as a functional target due to its homology to the BPTF gene, which is a well-studied chromatin remodeler involved in cancer[1][2][6].\n- Do not confuse BPTFP1 with BPTF in research or drug development contexts.\n\nIf you need data on the functional gene and potential drug target \"Bromodomain PHD finger transcription factor (BPTF)\", please clarify—this entry refers only to its nonfunctional pseudogene counterpart[1][2].

Other names

BPTFP1